Anticorps Polyclonal de lapin anti-SARS-CoV-2 Envelope Protein

SARS-CoV-2 Envelope Protein Polyclonal Antibody for ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Virus et plus (1)

Applications

WB, IF, ELISA

Conjugaison

Non conjugué

Publications(3)

N° de cat : 28904-1-AP

Synonymes

COV19, COV-19, COVID19, COVID-19 E protein, E Protein, envelope protein, SARS-COV-2 E Protein, SARS-CoV-2 Envelope Protein



Applications testées

Résultats positifs en ELISAProtéine recombinante

Dilution recommandée

ApplicationDilution
Test immuno-enzymatique (ELISA)ELISA :
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

28904-1-AP cible SARS-CoV-2 Envelope Protein dans les applications de WB, IF, ELISA et montre une réactivité avec des échantillons Virus

Réactivité Virus
Réactivité citéeHumain
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène SARS-CoV-2 Envelope Protein Protéine recombinante Ag30690
Nom complet COVID-19 E Protein
Numéro d’acquisition GenBankNC_045512
Symbole du gène SARS-CoV-2 Envelope Protein
Identification du gène (NCBI) 43740570
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStore at -20°C. Stable for one year after shipment. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

Envelope protein of coronaviruses is a structural protein existing in both monomeric and homopentameric form. It is a minor component of the virus membrane though it is deemed to be important for many stages including virus infection, replication, dissemination and immune response stimulation. Sequence comparison has shown that this protein is identical to the counterparts of specific Bat and Pangolin coronavirus isolates, even though the Sars-CoV-2 sequence seems to possess specific modifications and characteristics with respect to other Sars CoVs(PMID:32596311). The SARS-CoV-2 envelope protein provide a strategy to assess cross-protection against COVID-19 (PMID: 32446902).

Publications

SpeciesApplicationTitle
WB,IF

bioRxiv

Ubiquitin Ligase ITCH Regulates Life Cycle of SARS-CoV-2 Virus

Authors - Qiwang Xiang
humanIF

iScience

TLR2/NF-κB signaling in macrophage/microglia mediated COVID-pain induced by SARS-CoV-2 envelope protein

Authors - Huan Cui
humanIF

Front Cell Neurosci

The SARS-CoV-2 envelope protein disrupts barrier function in an in vitro human blood-brain barrier model

Authors - Jiahang Ju
{{ptg:RelatedPrimaryAntibodies}}